Loading…

Absence of the BRAF Mutation in HBME1 + and CK19+ Atypical Cell Clusters in Hashimoto Thyroiditis: Supportive Evidence Against Preneoplastic Change

An association between Hashimoto thyroiditis and papillary thyroid carcinoma has been postulated for decades. We undertook this study to identify potential precursors of papillary thyroid carcinoma in Hashimoto thyroiditis using a combination of morphologic, immunohistochemical, and molecular techni...

Full description

Saved in:
Bibliographic Details
Published in:American journal of clinical pathology 2009-12, Vol.132 (6), p.906-912
Main Authors: NASR, Michel R, MUKHOPADHYAY, Sanjay, SHENGLE ZHANG, KATZENSTEIN, Anna-Luise A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An association between Hashimoto thyroiditis and papillary thyroid carcinoma has been postulated for decades. We undertook this study to identify potential precursors of papillary thyroid carcinoma in Hashimoto thyroiditis using a combination of morphologic, immunohistochemical, and molecular techniques. For the study, samples from 59 cases of Hashimoto thyroiditis were stained with antibodies to HBME1 and cytokeratin (CK)19. Tiny HBME1+ and CK19+ atypical cell clusters were identified and analyzed for the BRAF mutation by the colorimetric Mutector assay and allele-specific polymerase chain reaction. HBME1+ and CK19+ atypical cell clusters were identified in 12 (20%) of 59 cases. The minute size (
ISSN:0002-9173
1943-7722
DOI:10.1309/AJCPCGCZZ1OYF0IC